Tweed and Bedrocan Canada Collaborate with Cannabis Health Clinic to Enroll Cannabis Dispensary Patients
SMITHS FALLS, ON, April 27, 2016 /CNW/ – Tweed Inc. (Tweed) and Bedrocan Canada Inc. (Bedrocan) are pleased to announce that, with the help of the Cannabis Health Clinic (CHC) in Regina, Saskatchewan, they have welcomed hundreds of new patients to the Marihuana for Medical Purposes Regulations (MMPR) system that were previously accessing medical cannabis through a dispensary. Tweed and Bedrocan Canada are proud to offer high quality medical cannabis to Canadians who have for years been accessing marijuana from sources outside the MMPR.
This conversion is the result of CHC’s decision to shift its business model to a health clinic that will help people access products from companies like Tweed and Bedrocan.
“I started out as a patient and found cannabis to be an effective treatment and then it evolved to a point where I was filling a larger need in the community, said Sean Murray, President of CHC. “Now with Tweed and Bedrocan I can help bridge the gap that exists between patients and producers. The general public needs educational resources and we want to steer people towards the system that’s set up to serve them.”
CHC patients and customers will now have the peace of mind that comes with being able to lawfully carry, consume, and travel within Canada with their much-needed medication.
We work with partners all across the country who help people access our products.
Mark Zekulin, President of Tweed
The Cannabis Health Clinic expressed a desire to transition their business and their clientele to the mainstream, regulated system and we’re proud to work with them to achieve that goal.
Tweed and Bedrocan started registering CHC customers in February and will continue to onboard additional clients moving forward.
Many Canadians have questions about medical cannabis and turn to resources in the community to find information. Tweed operates Main Street community engagement centres in Ontario and also has dozens of Certified Partner organizations that provide education on legal access points for medical cannabis. These strategies complement each other to create an environment that fosters a broader dialogue and understanding of medical cannabis and improved access where appropriate.
“We’re encouraged by the fact that as access and product diversity improves, interest in Tweed is coming from all corners of the industry,” said Zekulin.
Here’s to Future Growth.
About Tweed Inc.
Tweed Inc. is a Canadian company licensed under the Marihuana for Medical Purposes Regulations to produce and sell marijuana to authorized customers. Tweed strives to supply a wide selection of marijuana, as diverse as the patients who trust the company with their patronage. For more information visit www.tweed.com.
About Canopy Growth Corporation
Canopy Growth Corporation (TSX.V:CGC) is Canada’s first publicly traded medical marijuana company and the first geographically diversified producer with multiple licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Bedrocan Canada and Tweed Farms, the Company operates state-of-the-art production facilities throughoutOntario and distributes marijuana across the country to Canadian patients managing a host of medical conditions. The Company is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, and furthering the public’s understanding of how marijuana is used for medical purposes. www.canopygrowth.com
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or any of its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Although Canopy Growth Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The factors identified above are not intended to represent a complete list of the factors that could affect the Company or any of its subsidiaries. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
SOURCE Canopy Growth Corporation
For further information: Media Contact: Jordan Sinclair, Communications Manager, 855-558-9333 ex 309, Jordan@tweed.com; Investor Contact: Tyler Burns, Investor Relations, 855-558-9333 ex 122, firstname.lastname@example.org; Director: Bruce Linton CEO, Canopy Growth Corporation, email@example.com
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.